Overweight
📧 Sign up to get email alerts when something new happens for Overweight.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2025-12-18Clinical Trial Update: A Phase 3, Double-blind/Double-dummy, Safety/Efficacy/Superiority of Sibutramine/Topiramate XR in Adults With Overweight [Phase 3]
A Phase 3 trial evaluating sibutramine with extended-release topiramate in adults with overweight/obesity has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-09-05Clinical Trial Update: Fit Child - Clinical Study on Weight Control [NA]
A pediatric weight-control clinical trial named Fit Child (NCT03196453) sponsored by Turku University Hospital has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-06-05Clinical Trial Update: A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Obesity
A non-interventional pilot study sponsored by ProgenaBiome to investigate the role of gut flora in obesity has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-05-22Clinical Trial Update: Ultrasonic Treatment of Food Addiction [Phase 1, Phase 2]
Ultrasonic treatment trial for food addiction in overweight and obese participants has been withdrawn (Phase 1/Phase 2).
-
CLINICAL_TRIALS withdrawal · 2025-02-28Clinical Trial Update: Observational, Real-life, Retrospective, Data Collection, Use Sibutramine/topiramate in Overweight Comorbidities/obesity
A clinical trial evaluating the combination of sibutramine and topiramate for overweight/obesity in an observational retrospective data coll…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2020-09-21Clinical Trial Update: Antigen-Lipid-Driven Monoclonal Gammopathies Targeting Epicardial Fat [Phase 4]
A Phase 4 trial investigating antigen-lipid–driven monoclonal gammopathies targeting epicardial fat has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2018-06-29Clinical Trial Update: Improvement of Physical Activity and Correction of Body Mass Index in School Children [NA]
The clinical trial investigating improvements in physical activity and body mass index correction in overweight school children has been wit…
-
CLINICAL_TRIALS withdrawal · 2018-03-14Clinical Trial Update: Addressing Emotional and Cognitive Factors in Behavioral Weight Loss Treatment (Part 2) [NA]
A clinical trial studying the emotional and cognitive factors in a behavioral weight loss program has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-12-18Clinical Trial Update: The Effect of Modified Sham Feeding With Orlistat in Overweight and Obese Subjects [NA]
A clinical trial investigating modified sham feeding with orlistat in overweight and obese subjects has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-08-25Clinical Trial Update: Trial of a Culturally-Appropriate Weight Loss Intervention for Overweight Latino Children [NA]
A clinical trial evaluating a culturally appropriate weight loss intervention for overweight Latino children has been withdrawn.
-
EMA withdrawal · 2013-08-20EMA Application withdrawn: Belviq — Arena Pharmaceutical Enterprises Limited
The EMA withdrew the application for Belviq from Arena Pharmaceutical Enterprises Limited in the obesity/overweight therapeutic area.
-
CLINICAL_TRIALS withdrawal · 2013-02-21Clinical Trial Update: Intervention Study for Overweight and Obese Kindergarten Children [NA]
A clinical trial evaluating an intervention for overweight and obese kindergarten children has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2011-11-11Clinical Trial Update: DAWL (Dairy and Weight Loss) Study [Phase 4]
The Phase 4 DAWL study examining dairy and weight loss for obesity/overweight has been withdrawn.